GlassScriptPhysician profile
Raisa Morgan
NPI 1841941465
$868.28
in general payments reported to CMS, 2019-2025
21 companies · $496 in 2025
The $496 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $277 · 2023: $94.89 · 2025: $496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $591.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $590.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $156.45 | 2022-2025 | Wainua, Farxiga |
| Abiomed | $94.15 | 2025 | |
| Novartis Pharmaceuticals Corporation | $87.35 | 2022-2025 | |
| Novo Nordisk INC | $73.11 | 2022-2025 | Wegovy |
| Merck Sharp & Dohme LLC | $59.47 | 2022-2025 | Verquvo |
| Amgen INC. | $45.79 | 2022 | |
| Johnson & Johnson Health Care Systems INC. | $41.97 | 2023 | Opsumit |
| Boston Scientific Corporation | $41.29 | 2025 | General - Therapies |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.35 | 2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $33.00 | 2022-2025 | |
| W. L. Gore & Associates, INC. | $24.62 | 2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Corcept Therapeutics | $21.17 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $19.69 | 2025 | Opsynvi |
| Lilly USA, LLC | $18.43 | 2022 | |
| Paratek Pharmaceuticals, INC. | $18.12 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $17.74 | 2023 | Onpattro |
| Janssen Pharmaceuticals, INC | $17.50 | 2023 | Xarelto |
| Stryker Corporation | $16.82 | 2025 | Clottriever Bold Catheter |
| Solventum Corporation | $16.58 | 2025 | Activ.A.C., Promogran Prisma |
| Glaxosmithkline, LLC. | $13.08 | 2022 | |
| Zealand Pharma US, INC. | $12.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raisa Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.